A Study to Evaluate ALN-2232 in Participants With Obesity
Clinical trial NCT07463846 · RECRUITING
Trial details
- NCT number
- NCT07463846
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-04-27
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.